Evidence map›Paper›PMID 41492837›Full record

ReviewJournal of Korean medical science2026

Establishing an Active Vaccine Safety Surveillance System Using Large Scale Databases in Korea: Lessons and Scalable Insights for Global Application.

Jin Gu Yoon, Eliel Nham, Yu Jung Choi, Min Joo Choi, Won Suk Choi, Young Kyung Yoon, Yu Bin Seo, Hakjun Hyun, Jung Yeon Heo, Jin-Soo Lee and 4 more

Abstract readReview
In one paragraph

Review in Journal of Korean medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jin Gu YoonDivision of Infectious Diseases, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-3283-1880
Eliel NhamDivision of Infectious Diseases, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-7509-4863
Yu Jung ChoiDivision of Infectious Diseases, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0009-0008-1933-5843
Min Joo ChoiDivision of Infectious Diseases, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-2739-0948
Won Suk ChoiDivision of Infectious Diseases, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.ORCID https://orcid.org/0000-0001-5874-4764
Young Kyung YoonDivision of Infectious Diseases, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-8435-935X
Yu Bin SeoDivision of Infectious Diseases, Department of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-5183-1996
Hakjun HyunDepartment of Infectious Diseases, Ajou University School of Medicine, Suwon, Korea.ORCID https://orcid.org/0000-0002-1193-8948
Jung Yeon HeoDepartment of Infectious Diseases, Ajou University School of Medicine, Suwon, Korea.ORCID https://orcid.org/0000-0002-6548-1939
Jin-Soo LeeDivision of Infectious Diseases, Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea.ORCID https://orcid.org/0000-0001-7862-5519
Chung-Jong KimDepartment of Internal Medicine, Ewha Womans University Seoul Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0002-9987-6533
Ji Yun NohDivision of Infectious Diseases, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-8541-5704
Joon Young SongDivision of Infectious Diseases, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-0148-7194
Hee Jin CheongDivision of Infectious Diseases, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-2532-1463

Funding

Ministry of Food and Drug Safety 22183MFDS435
6 · The paper itself

Abstract

Vaccines are highly effective, but rare or delayed adverse events following immunization (AEFIs) require post-licensure surveillance beyond clinical trials. Korea lacks a comprehensive, active, database-based framework, yet key assets exist: nationwide claims databases (National Health Insurance Service/Health Insurance Review and Assessment Service), the national immunization registry (Korea Disease Control and Prevention Agency's Immunization Registry Information System) for National Immunization Program (NIP) and non-NIP vaccines, and increasingly standardized hospital electronic health records. We propose a federated, code to data architecture with data linkages between these data. Implementation should adopt a common data model (CDM), standardized case definitions, latency accounting, and transparent public reporting under strong privacy governance. Major challenges include multi step administrative approvals for data linkage, incomplete capture of adult non-NIP vaccinations, heterogeneous hospital data structures, and strict data protection constraints. Strategic priorities are to streamline statutory and administrative processes for public health use, mandate or enable claims-based capture of adult vaccinations, enhance CDM based interoperability, and develop secure hubs for aggregated outputs. With these measures, Korea will be well positioned to establish a scalable active surveillance system capable of detecting rare AEFIs, supporting transparent and evidence-based communication, and ensuring equitable injury compensation grounded in domestic data.

Indexed as

Databases, FactualProduct Surveillance, PostmarketingVaccinesAdverse Drug Reaction Reporting SystemsElectronic Health RecordsHumansImmunization ProgramsRegistriesRepublic of KoreaVaccinationVaccinesAdverse EffectsDatabaseKoreaSafetySurveillanceVaccines

Identifiers

PMID41492837
PMCPMC12775905

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.